ARKG

Fund Description
The Fund is concentrated in any industry or group of industries in the health care sector, including, in particular, issuers having their principal business activities in the biotechnology industry. Other industries in the health care sector include medical laboratories and research, drug manufacturers and agricultural chemicals.
Fund Profile
Fund Name ARK Genomic Revolution Multi-Sector ETF
Fund Exchange Ticker ARKG
Fund Sponsor ARK Funds
Fund ISIN US00214Q3020
Net Expense Ratio 0.75 %
Fund Inception Date 31 October 2014
Fund Legal Structure ETF (Open end fund)
Exchange BATS
Listing Country Code US
Fund Investment Objective
ETF Type Specific Global or ExUS Equities - Factor & Thematic
Asset Class Equities (Stocks)
Index Linked Active
Index Name Not Applicable
Index Provider Not Applicable
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Funds Combining Developed & Emerging Exposure
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent Not Applicable
Key Statistics
Return As of Date 22 September 2022
Asset Under Management 2370.10 Million (USD)
1 Month Total Return -13.49 %
Year To Date Return -46.16 %
1 Year Total Return -55.91 %
3 Year Annualized Total Return 5.48 %
NAV 32.9639
Share Outstanding 71,900,000
Top 10 Holdings (22 September 2022)
Constituent Name Constituent Ticker Constituent Type Weighting
EXACT SCIENCES CORP EXAS EQUI 0.0701000000
IONIS PHARMACEUTICALS INC IONS EQUI 0.0697000000
TELADOC HEALTH INC TDOC EQUI 0.0455000000
CRISPR THERAPEUTICS AG CRSP EQUI 0.0454000000
INTELLIA THERAPEUTICS INC NTLA EQUI 0.0428000000
BEAM THERAPEUTICS INC BEAM EQUI 0.0414000000
SIGNIFY HEALTH INC -CLASS A SGFY EQUI 0.0411000000
FATE THERAPEUTICS INC FATE EQUI 0.0395000000
SCHRODINGER INC SDGR EQUI 0.0393000000
CAREDX INC CDNA EQUI 0.0368000000